Search research articles
Contact Us
Filters
Showing results (31-40 of 407) with videos related to
Page
of 41
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 14, 2002
Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation
John R Cashman, Jun Zhang
Plos One
|
May 6, 2017
Deficiency of adaptive immunity does not interfere with Wallerian degeneration
Christopher R Cashman, Ahmet Hoke
Nature
|
January 25, 1990
EBV Ig-like domains
N R Cashman, Y Pouliot
Journal of Immunology (Baltimore, Md. : 1950)
|
June 15, 1986
Accessory cell competence of ovine oligodendrocytes in mitogenic activation of human peripheral T cells
N R Cashman, A Noronha
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 27, 2005
Quantitative analysis of FMO gene mRNA levels in human tissues
Jun Zhang, John R Cashman
Nature Reviews. Drug Discovery
|
October 2, 2004
Prion diseases--close to effective therapy?
Neil R Cashman, Byron Caughey
Journal of Medicinal Chemistry
|
July 1, 1991
Electron-deficient isoalloxazines: model systems for disulfide prodrug formation
J R Cashman, Y Liu
The Journal of Pharmacology and Experimental Therapeutics
|
October 8, 1997
N-oxygenation of phenethylamine to the trans-oxime by adult human liver flavin-containing monooxygenase and retroreduction of phenethylamine hydroxylamine by human liver microsomes
J Lin, J R Cashman
Chemical Research in Toxicology
|
August 1, 1997
Detoxication of tyramine by the flavin-containing monooxygenase: stereoselective formation of the trans oxime
J Lin, J R Cashman
Scientific Reports
|
June 10, 2020
PAWI-2 overcomes tumor stemness and drug resistance via cell cycle arrest in integrin β<sub>3</sub>-KRAS-dependent pancreatic cancer stem cells
Jiongjia Cheng, John R Cashman
Page
of 41
Search research articles
Search
Showing results (31-40 of 407) with videos related to
Sort By:
Page
of 41
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 14, 2002
Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation
John R Cashman, Jun Zhang
Plos One
|
May 6, 2017
Deficiency of adaptive immunity does not interfere with Wallerian degeneration
Christopher R Cashman, Ahmet Hoke
Nature
|
January 25, 1990
EBV Ig-like domains
N R Cashman, Y Pouliot
Journal of Immunology (Baltimore, Md. : 1950)
|
June 15, 1986
Accessory cell competence of ovine oligodendrocytes in mitogenic activation of human peripheral T cells
N R Cashman, A Noronha
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 27, 2005
Quantitative analysis of FMO gene mRNA levels in human tissues
Jun Zhang, John R Cashman
Nature Reviews. Drug Discovery
|
October 2, 2004
Prion diseases--close to effective therapy?
Neil R Cashman, Byron Caughey
Journal of Medicinal Chemistry
|
July 1, 1991
Electron-deficient isoalloxazines: model systems for disulfide prodrug formation
J R Cashman, Y Liu
The Journal of Pharmacology and Experimental Therapeutics
|
October 8, 1997
N-oxygenation of phenethylamine to the trans-oxime by adult human liver flavin-containing monooxygenase and retroreduction of phenethylamine hydroxylamine by human liver microsomes
J Lin, J R Cashman
Chemical Research in Toxicology
|
August 1, 1997
Detoxication of tyramine by the flavin-containing monooxygenase: stereoselective formation of the trans oxime
J Lin, J R Cashman
Scientific Reports
|
June 10, 2020
PAWI-2 overcomes tumor stemness and drug resistance via cell cycle arrest in integrin β<sub>3</sub>-KRAS-dependent pancreatic cancer stem cells
Jiongjia Cheng, John R Cashman
Page
of 41